Designation and Distribution of Events in the Multicenter UnSustained Tachycardia Trial (MUSTT)

John Devens Fisher, Alfred E. Buxton, Kerry L. Lee, Douglas L. Packer, Debra S. Echt, Pablo Denes, Michael H. Lehmann, John P. DiMarco, Denis Roy, Gail E. Hafley

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Patients with coronary artery disease, depressed left ventricular ejection fraction, and nonsustained ventricular tachycardia (VT) have a high mortality rate due to arrhythmic (arrhythmic death/cardiac arrest) and other cardiac causes. The Multicenter UnSustained Tachycardia Trial (MUSTT) investigated whether electrophysiologic study (EPS) was helpful in choosing drug or defibrillator therapy in patients induced into sustained VT. The events committee attempted to categorize follow-up events in patients in MUSTT and to present a detailed breakdown of events. A derivative of the Hinkle-Thaler classification was used, incorporating lessons from other multicenter studies. The committee was blinded to results of EPS and implantable cardioverter-defibrillator (ICD) or other antiarrhythmic therapy status of patients. The primary end point was cardiac arrest or death from arrhythmia. Secondary end points were death from all causes, cardiac causes, and spontaneous sustained VT. Classifications were death and cardiac arrest. Each was similarly divided as arrhythmic with 14 subcategories, e.g., unwitnessed or related to EPS and nonarrhythmic with 10 subcategories, e.g., ischemia. Terminal VF in progressive heart failure was considered nonarrhythmic. Events were reviewed by 2 members. Disagreements were resolved by the 2 members or, if needed, by the full committee. Of the 2,202 patients in MUSTT, there were 902 deaths. Sustained VT requiring cardioversion occurred in 182 patients. An additional 94 patients had resuscitated cardiac arrests. Events occurred in 1,027 patients, and all were reviewed. The 3 leading events were deaths that were classed as sudden/unwitnessed (23% of 902), due to progressive heart failure (22%), or due to noncardiovascular causes (18%). Arrhythmic deaths or cardiac arrests were highest in inducible patients randomized to no antiarrhythmic therapy; next were inducible patients receiving an ICD; and lowest were in patients who were noninducible. In conclusion, the classification system provided a detailed breakdown of events in consistent categories, showing utility for event analysis and interpretation and development of therapeutic strategies. The classifications assigned by the committee were used in all MUSTT outcomes reports, thus affecting all reported outcomes and overall interpretations of the MUSTT.

Original languageEnglish (US)
Pages (from-to)76-83
Number of pages8
JournalAmerican Journal of Cardiology
Volume100
Issue number1
DOIs
StatePublished - Jul 1 2007

Fingerprint

Tachycardia
Heart Arrest
Ventricular Tachycardia
Implantable Defibrillators
Heart Failure
Electric Countershock
Defibrillators
Therapeutics
Stroke Volume
Multicenter Studies
Cardiac Arrhythmias
Coronary Artery Disease
Cause of Death
Ischemia
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Designation and Distribution of Events in the Multicenter UnSustained Tachycardia Trial (MUSTT). / Fisher, John Devens; Buxton, Alfred E.; Lee, Kerry L.; Packer, Douglas L.; Echt, Debra S.; Denes, Pablo; Lehmann, Michael H.; DiMarco, John P.; Roy, Denis; Hafley, Gail E.

In: American Journal of Cardiology, Vol. 100, No. 1, 01.07.2007, p. 76-83.

Research output: Contribution to journalArticle

Fisher, JD, Buxton, AE, Lee, KL, Packer, DL, Echt, DS, Denes, P, Lehmann, MH, DiMarco, JP, Roy, D & Hafley, GE 2007, 'Designation and Distribution of Events in the Multicenter UnSustained Tachycardia Trial (MUSTT)', American Journal of Cardiology, vol. 100, no. 1, pp. 76-83. https://doi.org/10.1016/j.amjcard.2007.02.055
Fisher, John Devens ; Buxton, Alfred E. ; Lee, Kerry L. ; Packer, Douglas L. ; Echt, Debra S. ; Denes, Pablo ; Lehmann, Michael H. ; DiMarco, John P. ; Roy, Denis ; Hafley, Gail E. / Designation and Distribution of Events in the Multicenter UnSustained Tachycardia Trial (MUSTT). In: American Journal of Cardiology. 2007 ; Vol. 100, No. 1. pp. 76-83.
@article{fc6216b1c2864bc4b869985b91c38788,
title = "Designation and Distribution of Events in the Multicenter UnSustained Tachycardia Trial (MUSTT)",
abstract = "Patients with coronary artery disease, depressed left ventricular ejection fraction, and nonsustained ventricular tachycardia (VT) have a high mortality rate due to arrhythmic (arrhythmic death/cardiac arrest) and other cardiac causes. The Multicenter UnSustained Tachycardia Trial (MUSTT) investigated whether electrophysiologic study (EPS) was helpful in choosing drug or defibrillator therapy in patients induced into sustained VT. The events committee attempted to categorize follow-up events in patients in MUSTT and to present a detailed breakdown of events. A derivative of the Hinkle-Thaler classification was used, incorporating lessons from other multicenter studies. The committee was blinded to results of EPS and implantable cardioverter-defibrillator (ICD) or other antiarrhythmic therapy status of patients. The primary end point was cardiac arrest or death from arrhythmia. Secondary end points were death from all causes, cardiac causes, and spontaneous sustained VT. Classifications were death and cardiac arrest. Each was similarly divided as arrhythmic with 14 subcategories, e.g., unwitnessed or related to EPS and nonarrhythmic with 10 subcategories, e.g., ischemia. Terminal VF in progressive heart failure was considered nonarrhythmic. Events were reviewed by 2 members. Disagreements were resolved by the 2 members or, if needed, by the full committee. Of the 2,202 patients in MUSTT, there were 902 deaths. Sustained VT requiring cardioversion occurred in 182 patients. An additional 94 patients had resuscitated cardiac arrests. Events occurred in 1,027 patients, and all were reviewed. The 3 leading events were deaths that were classed as sudden/unwitnessed (23{\%} of 902), due to progressive heart failure (22{\%}), or due to noncardiovascular causes (18{\%}). Arrhythmic deaths or cardiac arrests were highest in inducible patients randomized to no antiarrhythmic therapy; next were inducible patients receiving an ICD; and lowest were in patients who were noninducible. In conclusion, the classification system provided a detailed breakdown of events in consistent categories, showing utility for event analysis and interpretation and development of therapeutic strategies. The classifications assigned by the committee were used in all MUSTT outcomes reports, thus affecting all reported outcomes and overall interpretations of the MUSTT.",
author = "Fisher, {John Devens} and Buxton, {Alfred E.} and Lee, {Kerry L.} and Packer, {Douglas L.} and Echt, {Debra S.} and Pablo Denes and Lehmann, {Michael H.} and DiMarco, {John P.} and Denis Roy and Hafley, {Gail E.}",
year = "2007",
month = "7",
day = "1",
doi = "10.1016/j.amjcard.2007.02.055",
language = "English (US)",
volume = "100",
pages = "76--83",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Designation and Distribution of Events in the Multicenter UnSustained Tachycardia Trial (MUSTT)

AU - Fisher, John Devens

AU - Buxton, Alfred E.

AU - Lee, Kerry L.

AU - Packer, Douglas L.

AU - Echt, Debra S.

AU - Denes, Pablo

AU - Lehmann, Michael H.

AU - DiMarco, John P.

AU - Roy, Denis

AU - Hafley, Gail E.

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Patients with coronary artery disease, depressed left ventricular ejection fraction, and nonsustained ventricular tachycardia (VT) have a high mortality rate due to arrhythmic (arrhythmic death/cardiac arrest) and other cardiac causes. The Multicenter UnSustained Tachycardia Trial (MUSTT) investigated whether electrophysiologic study (EPS) was helpful in choosing drug or defibrillator therapy in patients induced into sustained VT. The events committee attempted to categorize follow-up events in patients in MUSTT and to present a detailed breakdown of events. A derivative of the Hinkle-Thaler classification was used, incorporating lessons from other multicenter studies. The committee was blinded to results of EPS and implantable cardioverter-defibrillator (ICD) or other antiarrhythmic therapy status of patients. The primary end point was cardiac arrest or death from arrhythmia. Secondary end points were death from all causes, cardiac causes, and spontaneous sustained VT. Classifications were death and cardiac arrest. Each was similarly divided as arrhythmic with 14 subcategories, e.g., unwitnessed or related to EPS and nonarrhythmic with 10 subcategories, e.g., ischemia. Terminal VF in progressive heart failure was considered nonarrhythmic. Events were reviewed by 2 members. Disagreements were resolved by the 2 members or, if needed, by the full committee. Of the 2,202 patients in MUSTT, there were 902 deaths. Sustained VT requiring cardioversion occurred in 182 patients. An additional 94 patients had resuscitated cardiac arrests. Events occurred in 1,027 patients, and all were reviewed. The 3 leading events were deaths that were classed as sudden/unwitnessed (23% of 902), due to progressive heart failure (22%), or due to noncardiovascular causes (18%). Arrhythmic deaths or cardiac arrests were highest in inducible patients randomized to no antiarrhythmic therapy; next were inducible patients receiving an ICD; and lowest were in patients who were noninducible. In conclusion, the classification system provided a detailed breakdown of events in consistent categories, showing utility for event analysis and interpretation and development of therapeutic strategies. The classifications assigned by the committee were used in all MUSTT outcomes reports, thus affecting all reported outcomes and overall interpretations of the MUSTT.

AB - Patients with coronary artery disease, depressed left ventricular ejection fraction, and nonsustained ventricular tachycardia (VT) have a high mortality rate due to arrhythmic (arrhythmic death/cardiac arrest) and other cardiac causes. The Multicenter UnSustained Tachycardia Trial (MUSTT) investigated whether electrophysiologic study (EPS) was helpful in choosing drug or defibrillator therapy in patients induced into sustained VT. The events committee attempted to categorize follow-up events in patients in MUSTT and to present a detailed breakdown of events. A derivative of the Hinkle-Thaler classification was used, incorporating lessons from other multicenter studies. The committee was blinded to results of EPS and implantable cardioverter-defibrillator (ICD) or other antiarrhythmic therapy status of patients. The primary end point was cardiac arrest or death from arrhythmia. Secondary end points were death from all causes, cardiac causes, and spontaneous sustained VT. Classifications were death and cardiac arrest. Each was similarly divided as arrhythmic with 14 subcategories, e.g., unwitnessed or related to EPS and nonarrhythmic with 10 subcategories, e.g., ischemia. Terminal VF in progressive heart failure was considered nonarrhythmic. Events were reviewed by 2 members. Disagreements were resolved by the 2 members or, if needed, by the full committee. Of the 2,202 patients in MUSTT, there were 902 deaths. Sustained VT requiring cardioversion occurred in 182 patients. An additional 94 patients had resuscitated cardiac arrests. Events occurred in 1,027 patients, and all were reviewed. The 3 leading events were deaths that were classed as sudden/unwitnessed (23% of 902), due to progressive heart failure (22%), or due to noncardiovascular causes (18%). Arrhythmic deaths or cardiac arrests were highest in inducible patients randomized to no antiarrhythmic therapy; next were inducible patients receiving an ICD; and lowest were in patients who were noninducible. In conclusion, the classification system provided a detailed breakdown of events in consistent categories, showing utility for event analysis and interpretation and development of therapeutic strategies. The classifications assigned by the committee were used in all MUSTT outcomes reports, thus affecting all reported outcomes and overall interpretations of the MUSTT.

UR - http://www.scopus.com/inward/record.url?scp=34250754888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250754888&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2007.02.055

DO - 10.1016/j.amjcard.2007.02.055

M3 - Article

VL - 100

SP - 76

EP - 83

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -